Natixis Advisors LLC Purchases 20,589 Shares of Alexandria Real Estate Equities, Inc. $ARE

Natixis Advisors LLC raised its holdings in shares of Alexandria Real Estate Equities, Inc. (NYSE:ARE) by 15.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 157,493 shares of the real estate investment trust’s stock after purchasing an additional 20,589 shares during the quarter. Natixis Advisors LLC owned approximately 0.09% of Alexandria Real Estate Equities worth $13,125,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in ARE. Loomis Sayles & Co. L P purchased a new position in shares of Alexandria Real Estate Equities in the second quarter worth about $27,000. Avalon Trust Co purchased a new stake in shares of Alexandria Real Estate Equities during the 3rd quarter valued at approximately $29,000. Cornerstone Planning Group LLC boosted its holdings in Alexandria Real Estate Equities by 5,916.7% in the 3rd quarter. Cornerstone Planning Group LLC now owns 361 shares of the real estate investment trust’s stock worth $30,000 after buying an additional 355 shares during the period. CYBER HORNET ETFs LLC bought a new position in Alexandria Real Estate Equities in the 2nd quarter worth approximately $30,000. Finally, MUFG Securities EMEA plc purchased a new position in Alexandria Real Estate Equities in the 2nd quarter valued at approximately $33,000. Institutional investors own 96.54% of the company’s stock.

Alexandria Real Estate Equities Stock Performance

NYSE ARE opened at $50.23 on Friday. The company’s 50 day simple moving average is $54.16 and its two-hundred day simple moving average is $61.78. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.23 and a quick ratio of 0.23. Alexandria Real Estate Equities, Inc. has a 1 year low of $44.10 and a 1 year high of $101.21. The stock has a market capitalization of $8.70 billion, a PE ratio of -5.95, a P/E/G ratio of 6.08 and a beta of 1.31.

Alexandria Real Estate Equities (NYSE:ARE) last released its quarterly earnings results on Monday, January 26th. The real estate investment trust reported $2.16 EPS for the quarter, beating analysts’ consensus estimates of $2.15 by $0.01. The firm had revenue of $754.41 million during the quarter, compared to analyst estimates of $742.64 million. Alexandria Real Estate Equities had a negative net margin of 47.23% and a negative return on equity of 6.82%. The business’s revenue for the quarter was down 4.4% on a year-over-year basis. During the same period in the previous year, the business earned $2.39 EPS. Alexandria Real Estate Equities has set its FY 2026 guidance at 6.250-6.550 EPS. Analysts predict that Alexandria Real Estate Equities, Inc. will post 9.32 earnings per share for the current fiscal year.

Alexandria Real Estate Equities Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 15th. Investors of record on Tuesday, March 31st will be given a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 5.7%. The ex-dividend date is Tuesday, March 31st. Alexandria Real Estate Equities’s payout ratio is presently -34.12%.

Alexandria Real Estate Equities declared that its Board of Directors has approved a stock buyback program on Monday, December 8th that allows the company to buyback $500.00 million in shares. This buyback authorization allows the real estate investment trust to reacquire up to 6.4% of its shares through open market purchases. Shares buyback programs are usually a sign that the company’s management believes its shares are undervalued.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the stock. Jefferies Financial Group boosted their target price on shares of Alexandria Real Estate Equities from $47.00 to $57.00 and gave the company a “hold” rating in a report on Friday, January 30th. Mizuho cut their price target on Alexandria Real Estate Equities from $91.00 to $70.00 and set an “outperform” rating for the company in a report on Friday, January 9th. Citizens Jmp cut Alexandria Real Estate Equities from an “outperform” rating to a “market perform” rating in a research report on Thursday, November 13th. Cantor Fitzgerald boosted their price objective on Alexandria Real Estate Equities from $46.00 to $60.00 and gave the company a “neutral” rating in a research note on Wednesday, January 28th. Finally, Citigroup dropped their price objective on Alexandria Real Estate Equities from $61.00 to $52.00 and set a “neutral” rating on the stock in a report on Thursday, December 4th. Four investment analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $65.33.

Insider Buying and Selling

In other Alexandria Real Estate Equities news, Chairman Joel S. Marcus bought 25,000 shares of the firm’s stock in a transaction on Thursday, February 12th. The shares were acquired at an average cost of $53.92 per share, for a total transaction of $1,348,000.00. Following the purchase, the chairman directly owned 562,724 shares of the company’s stock, valued at $30,342,078.08. The trade was a 4.65% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.08% of the stock is currently owned by insiders.

Alexandria Real Estate Equities Profile

Alexandria Real Estate Equities, Inc (NYSE: ARE) is a real estate investment trust specializing in the ownership, development and management of collaborative life science and technology campuses. The company’s properties are designed to support research and innovation by providing specialized laboratory, office and manufacturing space tailored to biotechnology, pharmaceutical, academic and related industries.

Since its founding in 1994, Alexandria has cultivated a diversified portfolio of campuses across leading innovation clusters in North America and Europe.